Join to view full profile
11645 N Illinois StCarmel, IN 46032
Fax+1 314-265-2378
Dr. Roshal is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003- University of Rochester Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Rochester School of Medicine and DentistryClass of 1997
Certifications & Licensure
AZ State Medical License 2025 - 2028
IN State Medical License 2003 - 2025
MO State Medical License 2005 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
American Board of Internal MedicineHospice and Palliative Care
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2014, 2016
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2014, 2016
Clinical Trials
- Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies Start of enrollment: 2013 May 07
- Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
- VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors Start of enrollment: 2013 May 03
Publications & Presentations
PubMed
- Isolated Kaposi sarcoma of the upper aerodigestive tract in immunocompetent individuals, an underrecognized entity with favorable prognosis.Abdelrahman Shabaan, Ahmad Alkashash, Tieying Hou, Omer Saeed, Jessica Yesensky
Ear, Nose, & Throat Journal. 2025-03-01 - 14 citationsA phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.Jairam Krishnamurthy, Jingqin Luo, Rama Suresh, Foluso Ademuyiwa, Caron Rigden
NPJ Breast Cancer. 2022-03-21 - 30 citationsImmunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancerFoluso O. Ademuyiwa, Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann
Breast Cancer Research and Treatment. 2021-06-26
Press Mentions
Siteman Cancer Center to Open North St. Louis County Location July 1June 30th, 2017
Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting IllnessA Randomized Clinical TrialOctober 21st, 2016
How to Cope with and Discuss an Uncertain Cancer Prognosis: An Expert PerspectiveSeptember 8th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
